Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
TWEXIT
1 other identifier
observational
45
1 country
1
Brief Summary
A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2020
CompletedStudy Start
First participant enrolled
September 28, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2026
ExpectedFebruary 6, 2024
February 1, 2024
5 years
September 28, 2020
February 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Success rate of external cephalic version Twin A
Mean Percentage (Range 0-100) - Successfully performed external cephalic Versions / Total number of participants
4 hours after external cephalic version
Secondary Outcomes (10)
Fetal weight
30 Minutes before external cephalic version
Fetal Doppler Umbilical Pulsatility Index
30 Minutes before external cephalic version
Fetal Doppler Umbilical Resistance Index
30 Minutes before external cephalic version
Incidence of pathological cardiotocogramm
60 Minutes after external cephalic version
Incidence of emergency delivery
60 Minutes after external cephalic version
- +5 more secondary outcomes
Interventions
External Cephalic Version Twin A
Eligibility Criteria
All patients presenting with Twin A breech presentation to the antenatal clinic
You may qualify if:
- Presence of the written consent of the patients.
- The patients must be over 18 years old .
- No limit in the ability to consent.
You may not qualify if:
- Age under 18
- Limited ability to consent
- Placenta previa
- Fetal abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité University Hospital
Mitte, 10117, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larry Hinkson, FRCOG
Charité University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lead Consultant in Obstetrics, Deputy Director
Study Record Dates
First Submitted
September 28, 2020
First Posted
October 8, 2020
Study Start
September 28, 2020
Primary Completion
September 28, 2025
Study Completion (Estimated)
September 28, 2026
Last Updated
February 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share